Ray et al. prepared a PEI-based multi-drug co-delivery system that encapsulated doxorubicin, aspirin and BCL-2 siRNAs within NPs, and applied them to HCT116 cells to achieve superior anti-tumor effects [194]. Here, BCL2 is linked to neoplasm.